menu close
pathai.com
Pathai-Logo

PathAI Stock

Company Profile:

PathAI is a biotechnology company focused on improving patient outcomes through AI-powered pathology solutions. Founded to enhance the accuracy and efficiency of medical diagnoses, PathAI collaborates with biopharmaceutical companies, laboratories, and clinicians to provide advanced diagnostic tools.

Sign up for SecondMarket™ to view the market and buy or sell PathAI Stock
Buy + Sell

PathAI Funding

Sign up to gain insights into PathAI funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Apr 11, 2021 Series C 165.00M
Price
Valuation
Nov 04, 2019 Series B 15.00M
Price
Valuation
Apr 09, 2019 Series B 60.00M
Price
Valuation
Oct 18, 2017 Series A 3.47M
Price
Valuation
Oct 18, 2017 Series A 165.00K
Price
Valuation
Oct 18, 2017 Series A 11.10M
Price
Valuation
Oct 18, 2017 Series A 210.00K
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

PathAI Management Team

  • Director

    Michelle Dipp

  • Co-Founder, CEO, Director

    Andrew Beck

  • Chief Compliance Officer and Associate General Counsel

    Christian Krautkramer

  • Chief of Staff

    Tafadzwa Muguwe

  • Chief People Officer

    Liz Storti

  • Director

    Stanley N. Lapidus

  • Chief Medical Officer

    Eric Walk

  • Chief Scientific Officer

    Mike Montalto

  • Director

    Jeffrey Leiden

  • Chief Commercial Officer, Diagnostics

    Debora Greenblatt

  • Director

    Aditya Khosla

  • Chief Operating Officer

    Tiffany Freitas

PathAI Major Investors

  • Bristol-Myers Squibb Company

  • D1 Capital Partners

  • Danhua Capital LP

  • Tiger Global Management LLC

  • Biospring Management, LLC

  • Biospring Management, LLC

  • 8VC

  • Merck Global Health Innovation Fund LLC

  • General Atlantic LLC

  • Polaris Partners

  • General Catalyst Partners LLC

  • Adage Inc.

  • Pillar Companies

  • Refactor Capital

  • KdT Ventures

  • Kaiser Permanente Ventures

Learn More About PathAI Stock

Buy PathAI Stock
01
PathAI stock does not trade on public stock exchanges. PathAI stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in PathAI stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market. Get started to begin exploring private market opportunities.
Sell PathAI Stock
02
PathAI Stock does not trade on public stock exchanges. In order to sell PathAI shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors. Get started to begin exploring private market opportunities.
PathAI Stock Price
03
PathAI does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view PathAI share price and other valuable private market data. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
PathAI Stock Ticker Symbol
04
There is no ticker symbol for PathAI stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Criteria to Sell PathAI Stock
05
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell PathAI stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Criteria to Buy or Invest in PathAI Stock
06
Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in PathAI stock you need to be an institutional investor. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
PathAI Stock Settlement
07
Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
PathAI IPO
08
PathAI is a private company and has not had an IPO. There is currently no PathAI IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to PathAI IPO.

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Sign up for SecondMarket™ to view the market and buy or sell PathAI Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Headspin-Logo

Headspin

A Digital Experience AI Platform for mobile, web, audio, and video applications.

Grub Market - Logo

GrubMarket

Application for consumers to order fresh, locally-sourced food through their mobile and web apps.

Axiom Space-Logo

Axiom Space

Human spaceflight services and developer of human-rated space infrastructure.

Skydio-Logo

Skydio

Drone manufacturer and leader in autonomous flight.

Goat-Logo

Goat

Mobile marketplace for authentic sneaker transactions.

Odeko-Logo

Odeko

Mobile ordering and supply chain management platform for local cafés and eateries.

Source: Nasdaq Private Market Tape D™